Fig. 3From: Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigensThe ordered-scores map displays performance of the model for predicting disease progression following anti-PD-(L)1 monotherapy. Sample color codes, FSP color codes and axes labels and other abbreviations are defined in Fig. 1Back to article page